AZD0120 - Regimen 2 clinical trials

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

This study is testing a new treatment called AZD0120 for adults with multiple sclerosis (MS). It's a first step to see how safe the treatment is and if people can tolerate it well. We're looking at different types of MS to find the right dose.